BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Resource Type
Article
Authors
Chu, Quincy ; Leighl, Natasha B. ; Surmont, Veerle ; van Herpen, Carla ; Sibille, Anne ; Markman, Ben ; Clarke, Stephen ; Juergens, Rosalyn A. ; Rivera, Mirelis Acosta ; Andelkovic, Vladimir ; Rudin, Charles M. ; Snow, Stephanie ; Kim, Dong-Wan ; Sanatani, Michael ; Lin, Hongxia ; Sanghavi, Kinjal ; Tannenbaum-Dvir, Sarah ; Basciano, Paul ; Lathers, Deanne ; Urbanska, Katarzyna ; Kollia, Georgia ; He, Chunsheng ; DiPiero, Andrew ; Liu, Yu ; Ready, Neal
Source
In JTO Clinical and Research Reports November 2022 3(11)
Subject
Language
ISSN
2666-3643